US Stock MarketDetailed Quotes

Anixa Biosciences (ANIX)

Watchlist
  • 3.050
  • +0.010+0.33%
Close Apr 24 16:00 ET
  • 3.100
  • +0.050+1.64%
Post 20:01 ET
102.26MMarket Cap-9.53P/E (TTM)

Anixa Biosciences (ANIX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2026
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
0
0
0
Gross profit
0
0
0
0
Operating expense
-19.79%2.72M
-15.40%11.7M
-9.07%2.88M
-32.18%2.44M
-13.38%3M
-6.18%3.39M
25.05%13.83M
3.67%3.16M
26.30%3.59M
32.89%3.47M
Selling and administrative expenses
-12.00%1.61M
-10.83%6.63M
2.79%1.73M
-17.16%1.38M
-7.69%1.68M
-18.85%1.83M
18.18%7.44M
17.48%1.69M
-5.07%1.67M
13.04%1.82M
-General and administrative expense
-12.00%1.61M
-10.83%6.63M
2.79%1.73M
-17.16%1.38M
-7.69%1.68M
-18.85%1.83M
18.18%7.44M
17.48%1.69M
-5.07%1.67M
13.04%1.82M
Research and development costs
-28.99%1.1M
-20.72%5.07M
-22.63%1.14M
-45.19%1.06M
-19.68%1.32M
15.05%1.55M
34.12%6.4M
-8.61%1.48M
76.93%1.93M
64.93%1.65M
Operating profit
19.79%-2.72M
15.40%-11.7M
9.07%-2.88M
32.18%-2.44M
13.38%-3M
6.18%-3.39M
-25.61%-13.83M
-3.67%-3.16M
-26.30%-3.59M
-35.43%-3.47M
Net non-operating interest income expense
-24.28%131K
-40.60%673K
-38.40%154K
-43.68%156K
-33.80%190K
-45.77%173K
4.81%1.13M
-24.24%250K
-6.42%277K
13.44%287K
Non-operating interest income
-24.28%131K
-40.60%673K
-38.40%154K
-43.68%156K
-33.80%190K
-45.77%173K
4.81%1.13M
-24.24%250K
-6.42%277K
13.44%287K
Other net income (expense)
Income before tax
19.55%-2.59M
13.15%-11.03M
6.56%-2.72M
31.22%-2.28M
11.54%-2.81M
2.34%-3.21M
-27.88%-12.7M
-7.06%-2.91M
-30.10%-3.32M
-37.84%-3.18M
Income tax
Net income
19.55%-2.59M
13.15%-11.03M
6.56%-2.72M
31.22%-2.28M
11.54%-2.81M
2.34%-3.21M
-27.88%-12.7M
-7.06%-2.91M
-30.10%-3.32M
-37.84%-3.18M
Net income continuous Operations
19.55%-2.59M
13.15%-11.03M
6.56%-2.72M
31.22%-2.28M
11.54%-2.81M
2.34%-3.21M
-27.88%-12.7M
-7.06%-2.91M
-30.10%-3.32M
-37.84%-3.18M
Minority interest income
31.03%-20K
29.86%-101K
10.00%-27K
42.11%-22K
43.90%-23K
17.14%-29K
-21.01%-144K
3.23%-30K
-2.70%-38K
-115.79%-41K
Net income attributable to the parent company
19.44%-2.57M
12.96%-10.93M
6.52%-2.7M
31.10%-2.26M
11.12%-2.79M
2.18%-3.18M
-27.96%-12.55M
-7.17%-2.88M
-30.51%-3.28M
-37.19%-3.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.44%-2.57M
12.96%-10.93M
6.52%-2.7M
31.10%-2.26M
11.12%-2.79M
2.18%-3.18M
-27.96%-12.55M
-7.17%-2.88M
-30.51%-3.28M
-37.19%-3.14M
Basic earnings per share
20.00%-0.08
12.82%-0.34
0.00%-0.09
30.00%-0.07
10.00%-0.09
0.00%-0.1
-21.88%-0.39
0.00%-0.09
-25.00%-0.1
-42.86%-0.1
Diluted earnings per share
20.00%-0.08
12.82%-0.34
0.00%-0.09
30.00%-0.07
10.00%-0.09
0.00%-0.1
-21.88%-0.39
0.00%-0.09
-25.00%-0.1
-42.86%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Jan 31, 2026(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue 0000
Gross profit 0000
Operating expense -19.79%2.72M-15.40%11.7M-9.07%2.88M-32.18%2.44M-13.38%3M-6.18%3.39M25.05%13.83M3.67%3.16M26.30%3.59M32.89%3.47M
Selling and administrative expenses -12.00%1.61M-10.83%6.63M2.79%1.73M-17.16%1.38M-7.69%1.68M-18.85%1.83M18.18%7.44M17.48%1.69M-5.07%1.67M13.04%1.82M
-General and administrative expense -12.00%1.61M-10.83%6.63M2.79%1.73M-17.16%1.38M-7.69%1.68M-18.85%1.83M18.18%7.44M17.48%1.69M-5.07%1.67M13.04%1.82M
Research and development costs -28.99%1.1M-20.72%5.07M-22.63%1.14M-45.19%1.06M-19.68%1.32M15.05%1.55M34.12%6.4M-8.61%1.48M76.93%1.93M64.93%1.65M
Operating profit 19.79%-2.72M15.40%-11.7M9.07%-2.88M32.18%-2.44M13.38%-3M6.18%-3.39M-25.61%-13.83M-3.67%-3.16M-26.30%-3.59M-35.43%-3.47M
Net non-operating interest income expense -24.28%131K-40.60%673K-38.40%154K-43.68%156K-33.80%190K-45.77%173K4.81%1.13M-24.24%250K-6.42%277K13.44%287K
Non-operating interest income -24.28%131K-40.60%673K-38.40%154K-43.68%156K-33.80%190K-45.77%173K4.81%1.13M-24.24%250K-6.42%277K13.44%287K
Other net income (expense)
Income before tax 19.55%-2.59M13.15%-11.03M6.56%-2.72M31.22%-2.28M11.54%-2.81M2.34%-3.21M-27.88%-12.7M-7.06%-2.91M-30.10%-3.32M-37.84%-3.18M
Income tax
Net income 19.55%-2.59M13.15%-11.03M6.56%-2.72M31.22%-2.28M11.54%-2.81M2.34%-3.21M-27.88%-12.7M-7.06%-2.91M-30.10%-3.32M-37.84%-3.18M
Net income continuous Operations 19.55%-2.59M13.15%-11.03M6.56%-2.72M31.22%-2.28M11.54%-2.81M2.34%-3.21M-27.88%-12.7M-7.06%-2.91M-30.10%-3.32M-37.84%-3.18M
Minority interest income 31.03%-20K29.86%-101K10.00%-27K42.11%-22K43.90%-23K17.14%-29K-21.01%-144K3.23%-30K-2.70%-38K-115.79%-41K
Net income attributable to the parent company 19.44%-2.57M12.96%-10.93M6.52%-2.7M31.10%-2.26M11.12%-2.79M2.18%-3.18M-27.96%-12.55M-7.17%-2.88M-30.51%-3.28M-37.19%-3.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.44%-2.57M12.96%-10.93M6.52%-2.7M31.10%-2.26M11.12%-2.79M2.18%-3.18M-27.96%-12.55M-7.17%-2.88M-30.51%-3.28M-37.19%-3.14M
Basic earnings per share 20.00%-0.0812.82%-0.340.00%-0.0930.00%-0.0710.00%-0.090.00%-0.1-21.88%-0.390.00%-0.09-25.00%-0.1-42.86%-0.1
Diluted earnings per share 20.00%-0.0812.82%-0.340.00%-0.0930.00%-0.0710.00%-0.090.00%-0.1-21.88%-0.390.00%-0.09-25.00%-0.1-42.86%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More